Rare germline structural variants increase risk for pediatric solid tumors
Science · 03.01.2025 · 387 (6729)
DOI: 10.1126/science.adq0071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 03.01.2025. Verfasst von Riaz Gillani und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Hauptthemen laut MEDLINE: Bone Neoplasms, Genetic Predisposition to Disease, Genomic Structural Variation, Germ-Line Mutation. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Pediatric solid tumors are a leading cause of childhood disease mortality. In this work, we examined germline structural variants (SVs) as risk factors for pediatric extracranial solid tumors using germline genome sequencing of 1765 affected children, their 943 unaffected parents, and 6665 adult controls. We discovered a sex-biased association between very large (>1 megabase) germline chromosomal abnormalities and increased risk of solid tumors in male children. The overall impact of germline SVs was greatest in neuroblastoma, where we uncovered burdens of ultrarare SVs that cause loss of function of highly expressed, mutationally constrained genes, as well as noncoding SVs predicted to disrupt chromatin domain boundaries. Collectively, we estimate that rare germline SVs explain 1.1 to 5.6% of pediatric cancer liability, establishing them as an important component of disease predisposition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- Boston Children's Hospital, Boston, MA, USA.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Harvard/MIT MD-PhD Program, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Riaz Gillani, Ryan L Collins, Jett Crowdis, Amanda Garza, Jill K Jones, Mark Walker, Alba Sanchis-Juan, Christopher W Whelan, Michael E Talkowski, Jaclyn LoPiccolo, Alexander Gusev, Katherine A Janeway, Eliezer M Van Allen
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIMH NIH HHS
Zitieren
APA
Gillani, R., Collins, R. L., Crowdis, J., Garza, A., Jones, J. K., Walker, M., Sanchis-Juan, A., Whelan, C. W., Pierce-Hoffman, E., Talkowski, M. E., Brand, H., Haigis, K., LoPiccolo, J., AlDubayan, S. H., Gusev, A., Crompton, B. D., Janeway, K. A., & Van Allen, E. M. (2025). Rare germline structural variants increase risk for pediatric solid tumors. Science, 387(6729). https://doi.org/10.1126/science.adq0071
Vancouver
Gillani R, Collins RL, Crowdis J, Garza A, Jones JK, Walker M, et al. Rare germline structural variants increase risk for pediatric solid tumors. Science. 2025;387(6729). doi:10.1126/science.adq0071
BibTeX
@article{Gillani2025,
author = {Gillani, Riaz and Collins, Ryan L and Crowdis, Jett and Garza, Amanda and Jones, Jill K and Walker, Mark and Sanchis-Juan, Alba and Whelan, Christopher W and Pierce-Hoffman, Emma and Talkowski, Michael E and Brand, Harrison and Haigis, Kevin and LoPiccolo, Jaclyn and AlDubayan, Saud H and Gusev, Alexander and Crompton, Brian D and Janeway, Katherine A and Van Allen, Eliezer M},
title = {Rare germline structural variants increase risk for pediatric solid tumors},
journal = {Science},
year = {2025},
volume = {387},
number = {6729},
doi = {10.1126/science.adq0071}
}
EUVIMED